Dr. Destardi Moye-Sherman is a visionary leader and scientist dedicated to addressing health disparities and promoting equity within the healthcare sector. With over 25 years of outstanding achievements, she has earned a reputation as a seasoned and dynamic pharmaceutical team leader. Her expertise in Project Management, Research, Clinical Development, and CMC/Process Improvements reflects her multifaceted capabilities. Dr. Moye-Sherman consistently demonstrates a strategic mindset, skillfully navigating cross-functional complexities in drug development across a wide range of therapeutic areas and modalities.

Prior to joining E3 NexHealth, she served as Vice-President of Program Management at Immunome Inc. She played a pivotal role in establishing and building the Program Management function organization-wide, showcasing proficiency in coordinating development activities, strategic planning, budgeting, and risk management for the organization. She also partnered with Discovery and HR in implementing development training programs for the research team.

Drawing on her extensive leadership background across multiple Philadelphia area-based Pharma companies and biotechs including Merck, Shire, Cabaletta Bio, and Venatorx, Dr. Moye-Sherman showcases a collaborative approach that goes beyond organizational boundaries. She has deep experience in leading cross-functional teams across the drug development continuum from early phase IND enabling activities through submissions of NDA/MAA applications. She maintains a sharp focus on clinical, CMC and regulatory disciplines operating across multiple disease areas including oncology, anti-infectives, rare diseases, and diabetes. Whether fostering relationships with academic partners, engaged in business development and licensing activities, establishing, and strengthening program management functions, or managing external vendors, she consistently tackles the problems head-on with unwavering dedication and focus.

Dr. Moye-Sherman earned her PhD from Texas A&M University, where she received the Black and Hispanic Merit Fellowship and the National Institutes of Health Pre-Doctoral Fellowship. She also holds a BS in Chemistry from Howard University.

With her expertise, passion, and proven results, Dr. Moye-Sherman continues to drive progress and innovation in the pharmaceutical industry.